Celldex Therapeutics Stock Market Value
| CLDX Stock | USD 24.77 1.46 5.57% |
| Symbol | Celldex |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. Projected growth potential of Celldex fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Celldex Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.38) | Revenue Per Share | Quarterly Revenue Growth (0.71) | Return On Assets | Return On Equity |
Understanding Celldex Therapeutics requires distinguishing between market price and book value, where the latter reflects Celldex's accounting equity. The concept of intrinsic value—what Celldex Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Celldex Therapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Celldex Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Celldex Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Celldex Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Celldex Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Celldex Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Celldex Therapeutics.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Celldex Therapeutics on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Celldex Therapeutics or generate 0.0% return on investment in Celldex Therapeutics over 90 days. Celldex Therapeutics is related to or competes with Vera Therapeutics, Abcellera Biologics, Janux Therapeutics, Immunome, Biohaven Pharmaceutical, Spyre Therapeutics, and Uniqure NV. Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific ant... More
Celldex Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Celldex Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Celldex Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 13.96 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 6.44 |
Celldex Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celldex Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Celldex Therapeutics' standard deviation. In reality, there are many statistical measures that can use Celldex Therapeutics historical prices to predict the future Celldex Therapeutics' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.33) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celldex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Celldex Therapeutics January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 2.48 | |||
| Coefficient Of Variation | (8,318) | |||
| Standard Deviation | 3.19 | |||
| Variance | 10.2 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.33) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 13.96 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 6.44 | |||
| Skewness | 0.2449 | |||
| Kurtosis | 0.26 |
Celldex Therapeutics Backtested Returns
Celldex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0227, which signifies that the company had a -0.0227 % return per unit of risk over the last 3 months. Celldex Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Celldex Therapeutics' Standard Deviation of 3.19, insignificant risk adjusted performance, and Mean Deviation of 2.48 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.07, which signifies a somewhat significant risk relative to the market. Celldex Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Celldex Therapeutics is expected to follow. At this point, Celldex Therapeutics has a negative expected return of -0.0734%. Please make sure to confirm Celldex Therapeutics' standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and day median price , to decide if Celldex Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.16 |
Insignificant reverse predictability
Celldex Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Celldex Therapeutics time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Celldex Therapeutics price movement. The serial correlation of -0.16 indicates that over 16.0% of current Celldex Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.16 | |
| Spearman Rank Test | -0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.58 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.